↓ Skip to main content

Dove Medical Press

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia

Overview of attention for article published in Neuropsychiatric Disease and Treatment, March 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
6 news outlets
blogs
1 blog
twitter
4 X users
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
59 Mendeley
Title
Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
Published in
Neuropsychiatric Disease and Treatment, March 2015
DOI 10.2147/ndt.s80746
Pubmed ID
Authors

Jiří Masopust, Ctirad Andrýs, Jan Bažant, Oldřich Vyšata, Kamil Kuca, Martin Vališ

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Bangladesh 1 2%
Unknown 57 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Other 8 14%
Researcher 8 14%
Student > Bachelor 7 12%
Student > Ph. D. Student 6 10%
Other 9 15%
Unknown 12 20%
Readers by discipline Count As %
Medicine and Dentistry 22 37%
Agricultural and Biological Sciences 7 12%
Neuroscience 7 12%
Psychology 6 10%
Social Sciences 2 3%
Other 1 2%
Unknown 14 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 63. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2017.
All research outputs
#691,504
of 26,017,215 outputs
Outputs from Neuropsychiatric Disease and Treatment
#86
of 3,153 outputs
Outputs of similar age
#8,325
of 274,792 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#5
of 70 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,792 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.